Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakaria, Zaitun, Sapiai, Nur Asma, Ghani, Abdul Rahman Izaini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Case Report - Vascular Neurosurgery - Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186353/
https://www.ncbi.nlm.nih.gov/pubmed/34101024
http://dx.doi.org/10.1007/s00701-021-04860-w
Descripción
Sumario:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine.

Ejemplares similares